Related Experiment Video
Updated: Apr 28, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Type I interferon in the pathogenesis of lupus
1Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY 10021; and Rheumatology Division, Department of Medicine, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY 10065 crowm@hss.edu.
Type I Interferon (IFN-I), particularly IFN-α, is central to systemic lupus erythematosus pathogenesis. Research highlights IFN-I-driven immune responses and identifies potential therapeutic targets for lupus patients.
Area of Science:
- Immunology
- Autoimmune Diseases
- Innate Immunity
Background:
- Systemic lupus erythematosus (SLE) is a prototype autoimmune disease.
- The innate immune response, specifically Type I Interferons (IFN-I), plays a crucial role in SLE pathogenesis.
- IFN-α is identified as a dominant mediator within the IFN-I family.
Purpose of the Study:
- To define the central role of IFN-I in the pathogenesis of systemic lupus erythematosus.
- To explore genetic and molecular pathways contributing to lupus susceptibility.
- To identify potential therapeutic targets based on IFN-I-driven mechanisms.
Main Methods:
- Analysis of genetic association data in lupus patients.
- Investigation of innate immune response pathways, including TLR signaling and nucleic acid degradation.
- Examination of gene expression signatures in lupus blood and tissues, focusing on IFN-I-induced transcripts.
Main Results:
- Genetic data implicate nucleic acid degradation regulators and TLR pathway components in lupus susceptibility.
- A distinct gene expression signature characterized by IFN-I-induced transcripts is observed in lupus patients.
- These findings support IFN-I as a driver of the persistent autoimmune response in SLE.
Conclusions:
- IFN-I is a key driver of the immunologic and pathologic features of systemic lupus erythematosus.
- The immune response in lupus mimics a sustained antiviral response due to IFN-I activity.
- Understanding IFN-I's role opens avenues for novel therapeutic strategies currently under investigation.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Type I Diabetes II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Type I Diabetes I: Introduction
The JAK-STAT Signaling Pathway

